IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Fairmount Funds Management LLC

Portfolio Profile

CIK: 0001802528 | WEST CONSHOHOCKEN, PA

Investment Profile

Style

Aggressive Growth

Turnover

Medium

Orientation

Concentrated trader
$1.5B
AUM
12
Positions
97.65%
Top 10 Conc.
100%
Top 25 Conc.

Top Holdings

#SecuritySharesValue% of Portfolio
1Oruka Therapeutics Inc(ORKA)3,705,262$352.6M23.31%
2Dianthus Therapeutics Inc(DNTH)2,537,191$247.3M16.35%
3Damora Therapeutics Inc(GLTO)8,713,000$226.6M14.98%
4Cogent Biosciences Inc(COGT)5,503,418$213.0M14.08%
5Jade Biosciences Inc(JBIO)4,553,494$101.2M6.69%

Sector Allocation

Latest filing, equity positions only

Healthcare100% · $1.5B

Sector Rotation

Quarter-over-quarter weight changes

SectorPrev %Curr %Change
Healthcare100%100%0%

Cap Size Rotation

Quarter-over-quarter weight changes by market cap

Cap SizePrev %Curr %Change
Small Cap46.28%

AUM History

$831.2M | 20 pos.
$946.5M | 16 pos.
$917.4M | 15 pos.
$885.1M | 13 pos.
$1.2B | 15 pos.
$1.0B | 17 pos.
6
Enliven Therapeutics Inc(ELVN)
1,855,644
$94.2M
6.22%
7Viridian Therapeutics Inc(VRDN)5,090,928$93.5M6.18%
8Zenas Biopharma Inc(ZBIO)2,359,025$59.9M3.96%
9Crescent Biopharma Inc.(CBIO)2,747,866$49.5M3.27%
10Apogee Therapeutics Inc(APGE)298,647$39.6M2.62%
58.42%
+12.14%
Mid Cap52.67%39.23%-13.44%
Micro Cap1.05%2.35%+1.3%
$644.6M | 15 pos.
$771.9M | 17 pos.
$1.1B | 17 pos.
$1.3B | 13 pos.
$1.4B | 12 pos.
$1.5B | 12 pos.
Q3
23
Q4
23
Q1
24
Q2
24
Q3
24
Q4
24
Q1
25
Q2
25
Q3
25
Q4
25
Q1
26
Q2
26

Recent Activity

Quarter-over-quarter position changes

1
New
1
Closed
1
Increased
0
Decreased
10
Unchanged